Lee Tiedrich brings together an undergraduate education in electrical engineering and over twenty years of legal experience to assist clients on a broad range of intellectual property and technology transaction matters. Her work spans several industries, including ehealth, life sciences, consumer products, communications and media. She counsels both private and public companies, as well as venture capital firms and corporate venture groups in their investments. Ms. Tiedrich has extensive experience negotiating complex intellectual property acquisition, licensing, and development agreements, and regularly counsels clients on strategic issues, such as developing and maintaining intellectual property portfolios and evaluating and addressing intellectual property-related assets and risks.
On May 28, the White House Office of Science and Technology Policy (OSTP) hosted a meeting of the G7 Science & Technology (S&T) Ministers to collaborate on COVID-19 response and recovery. The G7 S&T Ministers emerged from the meeting with a declaration, in which they expressed their intent to: Enhance cooperation on shared COVID-19 research … Continue Reading
Artificial Intelligence (AI) has played an important role in battling COVID-19 since the initial outbreak: HealthMap – an AI tool from Boston Children’s Hospital that scans news reports, social media, and other data for signs of disease outbreaks – first sounded the international alarm after picking up reports of an emerging virus in Wuhan, China. … Continue Reading
Artificial intelligence (AI) is burgeoning in many industries, including healthcare. As the legal landscape around AI continues to evolve, how can organizations operationalize trustworthy AI applications? Lee Tiedrich and Lala R. Qadir share ten steps in this article with Law360. For more information about AI, please see our “AI Toolkit.”… Continue Reading
Lee Tiedrich, B.J. Altvater, and James Yoon recently published an article summarizing recent developments in artificial intelligence law and policy on the University of Pennsylvania Law School’s Regulatory Review. The article primarily focuses on developments in the United States, including the National Artificial Intelligence Initiative Act introduced by members of the House Committee on Science, Space, and Technology on March … Continue Reading
On April 8, 2020, the Federal Trade Commission (“FTC”) released a blog post about the use of artificial intelligence (“AI”) and algorithms in automated decisionmaking. The blog highlighted the potentially great benefits and risks presented by increasingly sophisticated technologies, particularly in the “Health AI” space. However, it also emphasized that automated decisionmaking is not a new phenomenon—and … Continue Reading
The rapid spread of COVID-19, along with the effectiveness of existing public health response plans and the impacts of social distancing on the economy, have raised the question of how new technology can be used to address and manage the pandemic. On April 1, 2020, the Stanford Institute for Human-Centered Artificial Intelligence hosted “COVID-19 and … Continue Reading
Healthcare providers, health plans, and other entities are increasingly utilizing cloud services to collect, aggregate, store and process data. A recent report by IDC Health Insights suggests that 80 percent of healthcare data is expected to pass through the cloud by 2020. As a substantial amount of healthcare data comprises “personal information” or “protected health … Continue Reading